Ocular Therapeutix, Inc. (OCUL) vs Taysha Gene Therapies, Inc. (TSHA)
- Ocular Therapeutix, Inc. OCUL 6.01 0.00%
- Taysha Gene Therapies, Inc. TSHA 4.01 −1.23%
Ocular Therapeutix, Inc. and Taysha Gene Therapies, Inc. are both Biotechnology companies. Ocular Therapeutix, Inc. and Taysha Gene Therapies, Inc. are of similar size ($1.3B and $1.3B). Taysha Gene Therapies, Inc. grew revenue faster over the last twelve months: 19.0% against −9.68%. Taysha Gene Therapies, Inc. has the higher net margin (0.00% vs −648.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Taysha Gene Therapies, Inc. leads on 13 and Ocular Therapeutix, Inc. on 3.
Valuation
Profitability
| Metric | OCUL | TSHA | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.32% | 100.00% | 70.18% |
| Operating margin | (680.91%) | 0.00% | 0.00% |
| Net margin | (648.64%) | 0.00% | 0.00% |
| Free cash flow margin | (530.00%) | 0.00% | 0.00% |
| Return on equity | (93.48%) | (54.18%) | (50.72%) |
| Return on assets | (64.30%) | (41.52%) | (45.56%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack